| Dr Peter Girard Meisner, DO | |
|
27351 Dequindre Rd, Madison Heights, MI 48071-3487 | |
| (248) 967-7795 | |
| (248) 967-7794 |
| Full Name | Dr Peter Girard Meisner |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 27351 Dequindre Rd, Madison Heights, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295187219 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101022328 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| St Petersburg General Hospital | Saint petersburg, FL | Hospital |
| Largo Medical Center | Largo, FL | Hospital |
| Tristar Southern Hills Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Augustine Emergency Physicians Llc | 0143492892 | 60 |
News Archive
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.
White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
Researchers almost always offer money as an incentive for healthy volunteers to enroll in research studies, but does payment amount to coercion or undue inducement to participate in research?
› Verified 8 days ago
| Entity Name | Sheridan Emergency Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598748030 PECOS PAC ID: 5597665372 Enrollment ID: O20040109000169 |
News Archive
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.
White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
Researchers almost always offer money as an incentive for healthy volunteers to enroll in research studies, but does payment amount to coercion or undue inducement to participate in research?
› Verified 8 days ago
| Entity Name | Augustine Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477124808 PECOS PAC ID: 0143492892 Enrollment ID: O20111003000107 |
News Archive
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.
White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
Researchers almost always offer money as an incentive for healthy volunteers to enroll in research studies, but does payment amount to coercion or undue inducement to participate in research?
› Verified 8 days ago
| Entity Name | Junco Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740664713 PECOS PAC ID: 3072821172 Enrollment ID: O20151008001706 |
News Archive
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.
White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
Researchers almost always offer money as an incentive for healthy volunteers to enroll in research studies, but does payment amount to coercion or undue inducement to participate in research?
› Verified 8 days ago
| Entity Name | Emergency Medicine Services Of Fl Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043917180 PECOS PAC ID: 8426413931 Enrollment ID: O20230504001881 |
News Archive
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.
White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
Researchers almost always offer money as an incentive for healthy volunteers to enroll in research studies, but does payment amount to coercion or undue inducement to participate in research?
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Girard Meisner, DO 27351 Dequindre Rd, Madison Heights, MI 48071-3487 Ph: (248) 967-7795 | Dr Peter Girard Meisner, DO 27351 Dequindre Rd, Madison Heights, MI 48071-3487 Ph: (248) 967-7795 |
News Archive
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.
White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
Researchers almost always offer money as an incentive for healthy volunteers to enroll in research studies, but does payment amount to coercion or undue inducement to participate in research?
› Verified 8 days ago
Elizabeth Ann Marcuz, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7000 | |
Kimberly F Heller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7661 | |
Arash Yekrangi-tajvidi, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795 Fax: 248-967-7794 | |
Sergey Tsekhanov, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795 Fax: 248-967-7794 | |
Matthew Boutorwick, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795 Fax: 248-967-7794 | |
Jenna Wonsowicz, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7661 Fax: 248-967-7876 | |
Gino Shwkat Etta, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7661 Fax: 248-967-7876 |